Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Whole Genome and Exome Sequencing market report explains the definition, types, applications, major countries, and major players of the Whole Genome and Exome Sequencing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Pacific Biosciences of California Inc
Beijing Genomics Institute (BGI)
Thermo Fisher Scientific Inc
Agilent Technologies Inc
GENEWIZ Inc
Bio-Rad Laboratories Inc
Oxford Nanopore Technologies Inc
Illumina Inc
Novogene Corporation
QIAGEN NV
Laboratory Corporation of America Holdings
Hoffmann-La Roche Ltd
Eurofins Scientific SE
Cytiva
By Type:
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
By End-User:
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres
Academia and Government Institutes
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Whole Genome and Exome Sequencing Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Whole Genome and Exome Sequencing Outlook to 2028- Original Forecasts
-
2.2 Whole Genome and Exome Sequencing Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Whole Genome and Exome Sequencing Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Whole Genome and Exome Sequencing Market- Recent Developments
-
6.1 Whole Genome and Exome Sequencing Market News and Developments
-
6.2 Whole Genome and Exome Sequencing Market Deals Landscape
7 Whole Genome and Exome Sequencing Raw Materials and Cost Structure Analysis
-
7.1 Whole Genome and Exome Sequencing Key Raw Materials
-
7.2 Whole Genome and Exome Sequencing Price Trend of Key Raw Materials
-
7.3 Whole Genome and Exome Sequencing Key Suppliers of Raw Materials
-
7.4 Whole Genome and Exome Sequencing Market Concentration Rate of Raw Materials
-
7.5 Whole Genome and Exome Sequencing Cost Structure Analysis
-
7.5.1 Whole Genome and Exome Sequencing Raw Materials Analysis
-
7.5.2 Whole Genome and Exome Sequencing Labor Cost Analysis
-
7.5.3 Whole Genome and Exome Sequencing Manufacturing Expenses Analysis
8 Global Whole Genome and Exome Sequencing Import and Export Analysis (Top 10 Countries)
-
8.1 Global Whole Genome and Exome Sequencing Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Whole Genome and Exome Sequencing Export by Region (Top 10 Countries) (2017-2028)
9 Global Whole Genome and Exome Sequencing Market Outlook by Types and Applications to 2022
-
9.1 Global Whole Genome and Exome Sequencing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global By Product Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Kits Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Instruments Consumption and Growth Rate (2017-2022)
-
9.1.4 Global By Workflow Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Whole Genome Sequencing (WGS) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Whole Exome Sequencing (WES) Consumption and Growth Rate (2017-2022)
-
9.2 Global Whole Genome and Exome Sequencing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical and Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic Labs Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Research Centres Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Academia and Government Institutes Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Whole Genome and Exome Sequencing Market Analysis and Outlook till 2022
-
10.1 Global Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.2.2 Canada Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.2.3 Mexico Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.2 UK Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.3 Spain Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.4 Belgium Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.5 France Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.6 Italy Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.7 Denmark Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.8 Finland Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.9 Norway Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.10 Sweden Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.11 Poland Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.12 Russia Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.3.13 Turkey Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.2 Japan Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.3 India Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.4 South Korea Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.5 Pakistan Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.6 Bangladesh Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.7 Indonesia Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.8 Thailand Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.9 Singapore Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.10 Malaysia Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.11 Philippines Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.4.12 Vietnam Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.2 Colombia Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.3 Chile Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.4 Argentina Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.5 Venezuela Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.6 Peru Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.7 Puerto Rico Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.5.8 Ecuador Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.6.2 Kuwait Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.6.3 Oman Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.6.4 Qatar Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.6.5 Saudi Arabia Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.6.6 United Arab Emirates Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.7.2 South Africa Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.7.3 Egypt Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.7.4 Algeria Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Whole Genome and Exome Sequencing Consumption (2017-2022)
-
10.8.2 New Zealand Whole Genome and Exome Sequencing Consumption (2017-2022)
11 Global Whole Genome and Exome Sequencing Competitive Analysis
-
11.1 Pacific Biosciences of California Inc
-
11.1.1 Pacific Biosciences of California Inc Company Details
-
11.1.2 Pacific Biosciences of California Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Pacific Biosciences of California Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.1.4 Pacific Biosciences of California Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Beijing Genomics Institute (BGI)
-
11.2.1 Beijing Genomics Institute (BGI) Company Details
-
11.2.2 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.2.4 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Thermo Fisher Scientific Inc
-
11.3.1 Thermo Fisher Scientific Inc Company Details
-
11.3.2 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.3.4 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Agilent Technologies Inc
-
11.4.1 Agilent Technologies Inc Company Details
-
11.4.2 Agilent Technologies Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Agilent Technologies Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.4.4 Agilent Technologies Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 GENEWIZ Inc
-
11.5.1 GENEWIZ Inc Company Details
-
11.5.2 GENEWIZ Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 GENEWIZ Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.5.4 GENEWIZ Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bio-Rad Laboratories Inc
-
11.6.1 Bio-Rad Laboratories Inc Company Details
-
11.6.2 Bio-Rad Laboratories Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bio-Rad Laboratories Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.6.4 Bio-Rad Laboratories Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Oxford Nanopore Technologies Inc
-
11.7.1 Oxford Nanopore Technologies Inc Company Details
-
11.7.2 Oxford Nanopore Technologies Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Oxford Nanopore Technologies Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.7.4 Oxford Nanopore Technologies Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Illumina Inc
-
11.8.1 Illumina Inc Company Details
-
11.8.2 Illumina Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Illumina Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.8.4 Illumina Inc Whole Genome and Exome Sequencing Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novogene Corporation
-
11.9.1 Novogene Corporation Company Details
-
11.9.2 Novogene Corporation Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novogene Corporation Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.9.4 Novogene Corporation Whole Genome and Exome Sequencing Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 QIAGEN NV
-
11.10.1 QIAGEN NV Company Details
-
11.10.2 QIAGEN NV Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 QIAGEN NV Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.10.4 QIAGEN NV Whole Genome and Exome Sequencing Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Laboratory Corporation of America Holdings
-
11.11.1 Laboratory Corporation of America Holdings Company Details
-
11.11.2 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.11.4 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Hoffmann-La Roche Ltd
-
11.12.1 Hoffmann-La Roche Ltd Company Details
-
11.12.2 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.12.4 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Eurofins Scientific SE
-
11.13.1 Eurofins Scientific SE Company Details
-
11.13.2 Eurofins Scientific SE Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.13.4 Eurofins Scientific SE Whole Genome and Exome Sequencing Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Cytiva
-
11.14.1 Cytiva Company Details
-
11.14.2 Cytiva Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Cytiva Whole Genome and Exome Sequencing Main Business and Markets Served
-
11.14.4 Cytiva Whole Genome and Exome Sequencing Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Whole Genome and Exome Sequencing Market Outlook by Types and Applications to 2028
-
12.1 Global Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global By Product Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Kits Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Instruments Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global By Workflow Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Whole Genome Sequencing (WGS) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Whole Exome Sequencing (WES) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pharmaceutical and Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Diagnostic Labs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Research Centres Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Academia and Government Institutes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Whole Genome and Exome Sequencing Market Analysis and Outlook to 2028
-
13.1 Global Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.2.2 Canada Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.2.3 Mexico Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.2 UK Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.3 Spain Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.4 Belgium Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.5 France Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.6 Italy Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.7 Denmark Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.8 Finland Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.9 Norway Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.10 Sweden Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.11 Poland Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.12 Russia Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.3.13 Turkey Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.2 Japan Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.3 India Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.4 South Korea Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.8 Thailand Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.9 Singapore Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.11 Philippines Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.2 Colombia Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.3 Chile Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.4 Argentina Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.6 Peru Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.6.3 Oman Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.6.4 Qatar Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.7.2 South Africa Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.7.3 Egypt Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.7.4 Algeria Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Whole Genome and Exome Sequencing Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Whole Genome and Exome Sequencing
-
Figure of Whole Genome and Exome Sequencing Picture
-
Table Global Whole Genome and Exome Sequencing Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Whole Genome and Exome Sequencing Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global By Product Consumption and Growth Rate (2017-2022)
-
Figure Global Kits Consumption and Growth Rate (2017-2022)
-
Figure Global Instruments Consumption and Growth Rate (2017-2022)
-
Figure Global By Workflow Consumption and Growth Rate (2017-2022)
-
Figure Global Whole Genome Sequencing (WGS) Consumption and Growth Rate (2017-2022)
-
Figure Global Whole Exome Sequencing (WES) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical and Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Labs Consumption and Growth Rate (2017-2022)
-
Figure Global Research Centres Consumption and Growth Rate (2017-2022)
-
Figure Global Academia and Government Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Table North America Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure United States Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Canada Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Mexico Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table Europe Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure Germany Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure UK Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Spain Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Belgium Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure France Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Italy Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Denmark Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Finland Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Norway Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Sweden Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Poland Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Russia Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Turkey Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table APAC Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure China Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Japan Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure India Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Thailand Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Singapore Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Philippines Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table South America Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure Brazil Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Colombia Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Chile Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Argentina Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Peru Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table GCC Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure Bahrain Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Oman Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Qatar Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table Africa Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure Nigeria Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure South Africa Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Egypt Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Algeria Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table Oceania Whole Genome and Exome Sequencing Consumption by Country (2017-2022)
-
Figure Australia Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Whole Genome and Exome Sequencing Consumption and Growth Rate (2017-2022)
-
Table Pacific Biosciences of California Inc Company Details
-
Table Pacific Biosciences of California Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pacific Biosciences of California Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Pacific Biosciences of California Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table Beijing Genomics Institute (BGI) Company Details
-
Table Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product Portfolio
-
Table Thermo Fisher Scientific Inc Company Details
-
Table Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table Agilent Technologies Inc Company Details
-
Table Agilent Technologies Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Agilent Technologies Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table GENEWIZ Inc Company Details
-
Table GENEWIZ Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table GENEWIZ Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table GENEWIZ Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table Bio-Rad Laboratories Inc Company Details
-
Table Bio-Rad Laboratories Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Bio-Rad Laboratories Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table Oxford Nanopore Technologies Inc Company Details
-
Table Oxford Nanopore Technologies Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford Nanopore Technologies Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Oxford Nanopore Technologies Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table Illumina Inc Company Details
-
Table Illumina Inc Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina Inc Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Illumina Inc Whole Genome and Exome Sequencing Product Portfolio
-
Table Novogene Corporation Company Details
-
Table Novogene Corporation Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novogene Corporation Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Novogene Corporation Whole Genome and Exome Sequencing Product Portfolio
-
Table QIAGEN NV Company Details
-
Table QIAGEN NV Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table QIAGEN NV Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table QIAGEN NV Whole Genome and Exome Sequencing Product Portfolio
-
Table Laboratory Corporation of America Holdings Company Details
-
Table Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product Portfolio
-
Table Hoffmann-La Roche Ltd Company Details
-
Table Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product Portfolio
-
Table Eurofins Scientific SE Company Details
-
Table Eurofins Scientific SE Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eurofins Scientific SE Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Eurofins Scientific SE Whole Genome and Exome Sequencing Product Portfolio
-
Table Cytiva Company Details
-
Table Cytiva Whole Genome and Exome Sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytiva Whole Genome and Exome Sequencing Main Business and Markets Served
-
Table Cytiva Whole Genome and Exome Sequencing Product Portfolio
-
Figure Global By Product Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kits Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Instruments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global By Workflow Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Whole Genome Sequencing (WGS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Whole Exome Sequencing (WES) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical and Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Labs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Centres Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academia and Government Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Table North America Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure United States Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure Germany Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure China Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure Brazil Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Whole Genome and Exome Sequencing Consumption Forecast by Country (2022-2028)
-
Figure Australia Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Whole Genome and Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
